Chagas Plataform in Bolivia
Main local partner: CEADES Fundation (http://www.coalicionchagas.org)
Other local partners: Ministry of Health; Programa Nacional de Chagas (http://www.msal.gob.ar/chagas/index.php/institucional/programa-nacional-de-chagas); local universities; social organization
Since 2004, the research group of FCRB, led by Dr. Joaquim Gascon, has been conducting epidemiological and clinical studies on Chagas disease in the immigrant Hispanic population in Spain (pregnant women, blood donors, etc.)
Also they continue to work for the knowledge of new tools for diagnosis and treatment, in assessing the effectiveness and safety of etiological treatment with benznidazole and collect data for the characterization of Chagas disease.
In 2010 they created in Bolivia the Platform for Comprehensive Care for Adult Patients with Chagas disease, with the financing of the Spanish Agency for International Cooperation and Development (AECID).
In 2015 AECID continues to finance the initiative against Chagas through a three-year agreement with a contribution of 2.500.000€.
The intervention strategy developed by FCRB focuses on three key areas:
1) Implement a model of care for the comprehensive management of patients with Chagas disease in the context of the reforms of national health system in Bolivia.
2) To strengthen and develop the capacities of health research in Bolivia (structures and equipment) and to generate new knowledge applicable to health programs as well as methods of diagnosis and treatment.
3) To provide to those responsible and health decision makers with some basic tools (rules, standards, reliable data) to guide the coordination of health programs.
Chagas disease is a chronic infectious tropical disease caused by the parasite Trypanosoma Cruzi, which is transmitted to animals and people by insect vectors that are found mainly in rural areas of Latin America where the disease is endemic. According to the WHO, Chagas disease affects between 8 and 10 million people in the world and, due to the mass migration it poses new challenges for the health systems of non-endemic areas such as Spain, which is the second country in the world, after the United States, with the most Latin American immigrant population. It is estimated that